SCHEMBL24725976

SCHEMBL24725976

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4-n4c5ccccc5c5ccccc54)cc3)c3ccc(-c4cccc5cccc(-c6ccccc6)c45)cc3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.39
ATM Q13315 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPK14 Q16539 1/20 0.33
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
MCL1 Q07820 1/20 0.31
BAD Q92934 1/20 0.31
MGLL Q99685 1/20 0.31
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA9 Q16790 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25686266 1.00 PDE6D (0.39) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL25686194 1.00 PDE6D (0.39) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL27011939 0.99 PDE6D (0.37) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL26767564 0.97 PDE6D (0.36) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL25686097 0.94 PDE6D (0.36) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL25686219 0.93 PDE6D (0.35) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL26767395 0.93 PDE6D (0.34) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL27012089 0.93 PDE6D (0.34) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL23618345 0.92 PDE6D (0.42) PDE6DATML3MBTL1KDM4EALDH1A1
SCHEMBL25686200 0.92 PDE6D (0.34) PDE6DATML3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230189638-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-15 US disclosed
US-20230189638-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-15 US disclosed
WO-2022199449-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING SAME, AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2022-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189638-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS THEREOF AOX1, PIEZO1, CYP2E1 PDE6D 3953/4885ATM 2438/4885L3MBTL1 3874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.